$VBNK

VersaBank (VBNK) Surpasses $7 Billion in Total Assets, Targets More US Growth

VersaBank (VBNK) reported Q3 2026 results with record credit assets, revenue, and net interest income, driven by US SRP growth. Total assets surpassed $7B. Net income rose 53% YoY, but EPS missed estimates. NIM declined due to liquidity and deposit rate pressures. The company targets $3B in new US SRP fundings for 2027. Restructuring costs and DRTC divestiture remain overhangs. Shares gained 49.50% YTD.

Original reporting
Published Sep 11, 2026, 6:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 6:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VersaBank (VBNK) Surpasses $7 Billion in Total Assets, Targets More US Growth — source image
Decision brief

The 30-second read

$VBNKBearishMed
01

Why it matters

The earnings release provides fresh guidance for FY2027 and reveals margin pressure, influencing short‑term price action and longer‑term growth outlook.

02

Market read

First‑report earnings with new guidance and asset milestone; material for traders monitoring niche banking stocks.

03

What to watch

Potential upside from the upcoming Real‑Time SRP launch and low short interest may limit downside.

Relevance 6/10Novelty 7/10Timing: post‑market September 3

Background

VersaBank is a cloud‑based, branchless B2B bank listed on NASDAQ, focusing on structured receivable financing in the US and Canada.

Company-level read

Ticker impact

$VBNKBearishMedium confidence
Context

VersaBank reported Q3 2026 results, beating asset milestone and providing FY guidance, with earnings miss versus consensus.

Expected impact

Potential short-term pullback of 5‑8% as investors digest the EPS miss.

Evidence & confidence

Revenue and asset growth are positive, but EPS fell short of expectations and margins compressed, which typically weighs on price.

Market effects

Highlights growth potential in niche B2B banking and structured receivable programs, may boost peer fintech lenders.

Shows US SRP expansion could influence Canadian banking sector sentiment.

Limited to North American regional banking niche.

Counterpoint

Despite the EPS miss, the $7 B asset milestone and US SRP pipeline could support upside if margins recover.

Key entities

  • VersaBank

    NASDAQ‑listed B2B bank reporting Q3 2026 results.

  • Insider Monkey

    Provider of hedge‑fund holdings data referenced in the article.

Related articles

$VBNKMed

VersaBank (VBNK) Q3 2026 Earnings Call Transcript

VersaBank (VBNK) reported Q3 2026 earnings with total revenue of CAD 38.8 million, up 23% YoY, and net income of CAD 10.1 million, up 53% YoY. Growth was driven by the U.S. Structured Receivable Program (SRP), which contributed nearly 25% of digital banking revenue. Total assets reached CAD 7.2 billion, and the company aims for significant growth in FY 2027, including a target of US$3 billion in U.S. SRP fundings.

Med

VersaBank (VBNK) (Q3 2026) Earnings Call Highlights: Record Assets Surpass $7

VersaBank reported Q3 2026 earnings with record assets of $7.2 billion. Net interest margin decreased to 2.44%, and non-core costs totaled $4.6 million. The CET1 ratio fell to 11.5%. Management targets $3 billion in U.S. fundings for 2027, with half from existing partners. The AI-enabled real-time SRP program is driving demand. Divestiture of DRTC cybersecurity business extended to August 2027. Core noninterest expenses are expected to remain stable. The bank aims for 20% ROE at $10 billion in a

$VBNKMed

VersaBank (VBNK): Financial results for FY2027

VersaBank (VBNK) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 FOR IMMEDIATE RELEASE: September 3, 2026 VERSABANK REPORTS STRONG THIRD QUARTER RESULTS: ACCELERATING US SRP GROWTH DRIVES 23% YEAR-OVER-YEAR INCREASE IN REVENUE, 53% GROWTH IN NET INCOME AND 27% GROWTH IN ADJUSTED (CORE) NET INCOME AS IT CONTINUES TO BENEFIT FROM OP

$VBNKMed

VersaBank (NASDAQ:VBNK) Shares Down 6.6% – What’s Next?

VersaBank (NASDAQ:VBNK) shares fell 6.6% in mid-day trading Thursday, trading between $18.30 and $18.74 versus a prior close of $20.07. Volume was 47,027 shares, down 21% from average. Analysts cited mixed views: consensus target $13.00. The bank reported Q1 EPS of $0.27 and revenue of $26.80M, and declared a $0.025 quarterly dividend.